AU2007201830C1 — High drug load tablet
Assigned to Novartis Pharma AG · Expires 2017-09-07 · 9y expired
What this patent protects
Abstract: The present invention pertains to a high drug load tablet comprising as active ingredient Compound I of formula H H N I I I NyN a N ./ N or a pharmaceutically acceptable salt thereof in an amount from about 30% to 80% in weight of the active moiety based on the total we…
USPTO Abstract
Abstract: The present invention pertains to a high drug load tablet comprising as active ingredient Compound I of formula H H N I I I NyN a N ./ N or a pharmaceutically acceptable salt thereof in an amount from about 30% to 80% in weight of the active moiety based on the total weight of the tablet.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.